Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence
NCT05860348 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5
Last updated 2025-04-08
Summary
The purpose of this study is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients that are symptomatic despite having received CRT.
Conditions
Interventions
- DEVICE
-
Barostim™ System
Implantation of the Barostim™ System
Sponsors & Collaborators
-
CVRx, Inc.
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-25
- Primary Completion
- 2024-09-04
- Completion
- 2024-12-11
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation
NCT04098328 ·Status: TERMINATED
-
HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation
NCT05409378 ·Status: WITHDRAWN ·Phase: NA
-
Reprieve System Pilot Study
NCT06272734 ·Status: RECRUITING ·Phase: NA
-
Cardiovalve Transfemoral Mitral Valve System
NCT03813524 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Caisson Transcatheter Mitral Valve Replacement (TMVR)
NCT03661398 ·Status: UNKNOWN ·Phase: NA
-
Identifying and Facilitating Ventricular Recovery on Mechanical Support
NCT00687856 ·Status: COMPLETED
-
Cardiovascular Diagnosis Using µ-Cor - an Interventional Pilot Trial
NCT02700191 ·Status: WITHDRAWN ·Phase: NA
-
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing
NCT02006069 ·Status: TERMINATED ·Phase: NA
-
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
NCT02276547 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
NCT02205411 ·Status: TERMINATED ·Phase: NA
-
Phase II Clinical Trial of Percutaneous Ventricular Restoration Using Heartech® Device Preventing Heart Failure Post Myocardial Infarction (The Partical Study)
NCT04039256 ·Status: UNKNOWN ·Phase: NA
-
Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation
NCT03560167 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Improvements With MV ASV Therapy in Heart Failure
NCT01953874 ·Status: TERMINATED ·Phase: NA
-
Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study
NCT05637242 ·Status: TERMINATED
-
Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF
NCT02985268 ·Status: WITHDRAWN ·Phase: NA
-
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
NCT02790242 ·Status: TERMINATED
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NCT04100720 ·Status: WITHDRAWN ·Phase: NA
-
Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD
NCT03279861 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NCT07140562 ·Status: RECRUITING ·Phase: NA
-
HF Patients With LVADs Being Treated With SGLT2i
NCT05278962 ·Status: COMPLETED ·Phase: PHASE4
-
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NCT04717570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS
NCT00710567 ·Status: TERMINATED ·Phase: NA
-
Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation
NCT06414265 ·Status: RECRUITING ·Phase: NA